Nuclear receptor RORγ inverse agonists/antagonists display tissue- and gene-context selectivity through distinct activities in altering chromatin accessibility and master regulator SREBP2 occupancy.
- Publication date
- 1 August 2022
- Publisher
- eScholarship, University of California